Lv41
500 积分 2026-04-13 加入
Combination Therapy for Mucormycosis: Why, What, and How?
2个月前
已完结
Risk Factors of Rapid FEV<sub>1</sub> Decline in a Real-World Chronic Obstructive Pulmonary Disease Cohort
2个月前
已完结
Early Diagnosis and Treatment of COPD and Asthma — A Randomized, Controlled Trial
2个月前
已完结
Transparent reporting of observational studies emulating a target trial: the TARGET Statement
2个月前
已完结
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
2个月前
已完结
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
2个月前
已完结
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
2个月前
已完结
Comparative Effectiveness and Safety of LAMA-LABA Inhalers in Chronic Obstructive Pulmonary Disease
2个月前
已完结
皖公网安备34019202002308
